The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Find out more about Cancellations and Suspensions.
Cancellations and suspensions
This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Medical device cancellation (832)
- Medicine suspension (506)
- Complementary medicine cancellation (203)
- Medical device suspension (86)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (51)
- Medical device cancellation - certain devices within an entry (23)
- Registered medicine cancellation (12)
- Voluntary revocation at the request of the manufacturer (9)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (3)
- Listed medicine cancellation (3)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (2)
- Revoked medicine suspension (2)
- AFT Pharmaceuticals Pty Ltd (1)
- Alphapharm Pty Ltd (1)
- Medical device cancellation (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Search
1821 result(s) found, displaying 1801 to 1821
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s26A(2)(c) and (j) were incorrect., effective 16/08/2013
-
Cancellation or suspensionRegulatory action due to As the kind of medical device included in the Register was not correctly classified and the sponsor failed to provide evidence that an appropriate conformity assessment procedure has been applied to the device, the certifications made under s.41FD(c) and (f) were incorrect., effective 05/08/2013
-
Cancellation or suspensionRegulatory action due to As the kind of medical device included in the Register was not correctly classified, the certification made by the applicant under s.41FD(c) was incorrect., effective 12/07/2013
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s26A(2)(c) and (j) were incorrect. The goods also did not conform to a requirement relating to advertising applicable to the goods under Part 5-1 of the Act., effective 05/07/2013
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply within the required timeframe with a notice under section 31 of the Act requiring it to provide information about whether the product should have been listed., effective 02/07/2013
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply within the required timeframe with a notice under section 31 of the Act requiring it to provide information about whether the product should have been listed., effective 28/06/2013
-
Cancellation or suspensionRegulatory action due to The goods: are not eligible for listing as the indication was for the treatment of a condition specified in Part 2 of Appendix 6 to the TGAC (see item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations); have changed so that they have become separate and distinct from the goods in the ARTG. The sponsor has failed to comply with a condition of listing under s28(5)(ab) (that the goods would not advertise the goods for an indication other than those accepted in the Register). The certification under s26A(2)(c) (that the presentation of the goods is not unacceptable) is incorrect., effective 14/06/2013
-
Cancellation or suspensionRegulatory action due to The goods are not eligible for listing as the indication was for the treatment of a condition specified in Part 2 of Appendix 6 to the TGAC (see item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations). The sponsor has failed to comply with a condition of listing under s28(5)(ab) (that the goods would not advertise the goods for an indication other than those accepted in the Register)., effective 14/06/2013
-
Cancellation or suspensionRegulatory action due to The goods: have changed so that they have become separate and distinct from the goods in the ARTG; and do not conform to a standard applicable to the goods., effective 04/06/2013
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect.The goods do not conform to a requirement relating to advertising applicable to the goods under Part 5-1 of the Act., effective 17/05/2013
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect. The goods do not conform to a requirement relating to advertising applicable to the goods under Part 5-1 of the Act., effective 08/05/2013
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect., effective 04/04/2013
-
Cancellation or suspensionRegulatory action due to As the presentation of the product was unacceptable, the certification made by the applicant under s.26A(2)(c) was incorrect. The goods also did not conform to regulatory requirements relating to advertising (paragraph 30(2)(e))., effective 27/03/2013
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect (paragraph 30(2)(ba)). The goods also did not conform to regulatory requirements relating to advertising (paragraph 30(2)(e)., effective 25/02/2013
-
Cancellation or suspensionRegulatory action due to Sponsor failed to comply with notice under section 31 of the Act requiring it to provide information about whether the product should have been listed., effective 04/01/2013
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect. Failed to comply with a condition of listing under s.28(5)(ab) of the Act., effective 11/12/2012
-
Cancellation or suspensionRegulatory action due to As the medicine is now required to be included in another part of the Register under ss.10B(1)(a) and ss.10B(7)(b)(i), the medicine has became ineligible for listing s.30(1A)(a) of the Act., effective 23/11/2012
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect., effective 09/10/2012
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product, the certification made by the applicant under s.26A(2)(j) was incorrect., effective 09/10/2012
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product and the presentation of the product was unacceptable, the certifications made by the applicant under s.26A(2)(c) and (j) were incorrect., effective 15/08/2012
-